alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › pilot

pilot

9 studies tagged pilot, dated 2009-06-16 to 2025-05-20. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial 2025-05-20
  2. Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer's disease among Asian Americans and Canadians 2024-01-12
  3. Comparing the effects of olfactory-based sensory stimulation and board game training on cognition, emotion, and blood biomarkers among individuals with dementia: A pilot randomized controlled trial 2022-09-20

Studies

9 studies carry this tag.

Date range

2009 to 2025

Top journals

  • Age and ageing 1
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • American journal of Alzheimer's disease and other dementias 1
  • Communications medicine 1
  • Experimental gerontology 1

9 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Communications medicine 2025-05-20 Biomarkers

    Rapamycin is not detectable in the CSF before or after treatment, but several Alzheimer's disease and inflammatory biomarkers increase after treatment.

  2. Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer's disease among Asian Americans and Canadians

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-01-12 Biomarkers

    ACAD's traction indicates the feasibility of recruiting Asians for clinical research to enhance understanding of AD risk factors.

  3. Comparing the effects of olfactory-based sensory stimulation and board game training on cognition, emotion, and blood biomarkers among individuals with dementia: A pilot randomized controlled trial

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Frontiers in psychology 2022-09-20 Biomarkers

    Olfactory dysfunction can indicate early cognitive decline and is associated with dementia symptoms.

  4. Evaluation of BCG Vaccination and Plasma Amyloid: A Prospective, Pilot Study with Implications for Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Microorganisms 2022-02-12 Biomarkers

    BCG vaccine has been used for 100 years to prevent tuberculosis.

  5. Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of Alzheimer's disease : JAD 2018-01-01 Biomarkers

    Gait disturbances are some of the earliest changes in dementia and their monitoring presents an opportunity for early diagnosis.

  6. Cerebrospinal fluid biomarkers of Alzheimer's disease in Chinese patients: a pilot study

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. American journal of Alzheimer's disease and other dementias 2013-10-01 Biomarkers

    In view of the paucity of data on cerebrospinal fluid (CSF) biomarkers in Chinese patients, we evaluated the validity of tau, phosphorylated tau 181 (p-tau-181), amyloid β 42 (Aβ42), and Aβ40 proteins in Chinese patients with Alzheimer's disease (AD).

  7. Platelet immunoglobulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: findings from a pilot study

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Age and ageing 2012-01-17 Biomarkers

    Since cerebrospinal fluid analysis and molecular neuroimaging are not routinely used in many countries, blood biomarker molecules may be more readily applicable in a routine clinical setting.

  8. Serum amyloid beta protein in young and elderly depression: a pilot study

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society 2009-12-01 Biomarkers

    Serum Abeta40/42 ratio was significantly higher in MDD patients than in controls, and this difference was seen for both elderly and young subjects.

  9. Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI)

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Experimental gerontology 2009-06-16 Biomarkers

    The use of frozen rather than fresh samples renders higher diagnostic accuracy within a multicentre context.

All topic tags with their study counts